Antimicrobial resistance in gram-negative bacteria from developing countries

Antimicrobial Resistance in Developing Countries

Volumn 9780387893709, Issue , 2010, Pages 249-266

  De Andrade, Soraya Sgambatti ^a   Gales, Ana Cristina ^a   Sader, Helio Silva ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Jones Group/JMI Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855513068     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-89370-9_14     Document Type: Chapter

References (50)

1. Andrade, S. S., Jones, R. N., Gales, A. C., and Sader, H. S. 2003. "Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997-2001) ". Journal of Antimicrobial Chemotherapy 52:140-141.
2. Baraniak, A., Fiett, J., Sulikowska, A., Hryniewicz, W., and Gniadkowski, M. 2002. "Countrywide spread of CTX-M-3 extended-spectrum b-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland." Antimicrobial Agents and Chemotherapy 46:151-159.
3. Bell, J. M., Turnidge, J. D., and Jones, R. N. 2003. "Prevalence of extended-spectrum b-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: Results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001." Antimicrobial Agents and Chemotherapy 47:3989-3993.
4. Bell, J. M., Turnidge, J. D., Walters, L. J., and Jones, R. N. 2007. "Emergence and widespread dissemination of OXA-23, -24 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific Surveillance Program (2006) ", Abstract C2-1510a. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, IL, 228.
5. Biedenbach, D. J., Toleman, M., Walsh, T. R., and Jones, R. N. 2006. "Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004)." Diagnostic Microbiology and Infectious Diseases 54:13-21.
6. Brink, A., Moolman, J., da Silva, M. C., and Botha, M. 2007. "Antimicrobial susceptibility profile of selected bacteraemic pathogens from private institutions in South Africa." South African Medical Journal 97:273-279.
7. Castanheira, M., Bell, J. M., Jones, R. N., Mathai, D., and Turnidge, J. D. 2008. "High carbapenem resistance among Pseudomonas aeruginosa from India: A national epidemic of multiple metallo-β-lactamase clones (VIM-2, -5, -6, -11 and new VIM-18) ", Abstract P900. 18th European Congress of Clinical Microbiology and Infectious Diseases (ECC-MID), Barcelona, Spain.
8. Castanheira, M., Bell, J. M., Turnidge, J. D., Mendes, R. E., Sader, H. S., and Jones, R. N. 2007a. "Dissemination and genetic context analysis of blaVIM-6 among Pseudomonas aeruginosa in Asia-Pacific Nations", Abstract C1-109a. 47th International Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, IL.
9. Castanheira, M., Mendes, R. E., Picao, R. C., Pinto, F. P., Machado, A. M. O., Walsh, T. R., and Gales, A. C. 2006. "Genetic analysis of a multidrug-resistant (MDR) Enterobacter cloacae producing IMP-1 metallo-b-lactamase (MBL), Abstract C1-63." 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, CA, 72.
10. Castanheira, M., Pereira, A. S., Nicoletti, A. G., Pignatari, A. C., Barth, A. L., and Gales, A. C. 2007b. "First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America." Antimicrobial Agents and Chemotherapy. 51:527-1529.
11. CDC. 2003. Centers for Disease Control and Prevention: National Center for Infectious Disease and World Health Organization: Department of Communicable Disease Surveillance and Response. Manual for the laboratory identification and antimicrobial susceptibility testing of bacterial pathogens of public health importance in the developing world: Haemophilus influenzae, Neisseria meningitidis, Streptococcus pneumoniae, Salmonella serotype Typhi, Shigella and Vibrio cholerae. Chapter IV P 29-43. WHO/CDS/CSR/RMD/2003.6. Available from http://www.who.int/csr/resources/publications/drugresist/WHO-CDS-CSR-RMD-2003-6/3n/.
12. Chau, T. T., Campbell, J. I., Galindo, C. M., Van Minh Hoang, N., Diep, T. S., Nga, T. T., Van Vinh Chau, N., Tuan, P. Q., Page, A. L., Ochiai, R. L., Schultsz, C., Wain, J., Bhutta, Z. A., Parry, C. M., Bhattacharya, S. K., Dutta, S., Agtini, M., Dong, B., Honghui, Y., Anh, D. D., Canh do, G., Naheed, A., Albert, M. J., Phetsouvanh, R., Newton, P. N., Basnyat, B., Arjyal, A., La, T. T., Rang, N. N., Phuong le, T., Van Be Bay, P., von Seidlein, L., Dougan, G., Clemens, J. D., Vinh, H., Hien, T. T., Chinh, N. T., Acosta, C. J., Farrar, J., and Dolecek, C. 2007. "Antimicrobial drug resistance of Salmonella enterica Serovar Typhi in Asia and molecular mechanism of reduced susceptibility to the fluoroquinolones." Antimicrobial Agents and Chemotherapy 51:4315-4323.
13. Crawford, S. A., Fiebelkorn, K. R., Patterson, J. E., Jorgensen, and J. H. 2005. "International clone of Neisseria meningitidis serogroup A with tetracycline resistance due to tet (B)." Antimicrobial Agents and Chemotherapy 49:1198-1200.
14. Daoud, Z., Moubareck, C., Hakime, N., and Doucet-Populaire, F. 2006. "Extended-spectrum β-lactamase producing Enterobacteriaceae in Lebanese ICU patients: Epidemiology and patterns of resistance." The Journal of General and Applied Microbiology 52:169-178.
15. Dillon, J. A., Ruben, M., Li, H., Borthagaray, G., Marquez, C., Fiorito, S., Galarza, P., Portilla, J. L., Leon, L., Agudelo, C. I., Sanabria, O. M., Maldonado, A., and Prabhakar, P. 2006. "Challenges in the control of gonorrhea in South America and the Caribbean: monitoring the development of resistance to antibiotics." Sexually Transmitted Diseases 33:87-95.
16. Dromigny, J. A., Ndoye, B., Macondo, E. A., Nabeth, P., Siby, T., and Perrier-Gros-Claude, J. D. 2003. "Increasing prevalence of antimicrobial resistance among Enterobacteriaceae uropathogens in Dakar, Senegal: A multicenter study." Diagnostic Microbiology and Infectious Diseases 47:595-600.
17. Galanis, E., Lo Fo Wong, D. M., Patrick, M. E., Binsztein, N., Cieslik, A., Chalermchikit, T., Aidara-Kane, A., Ellis, A., Angulo, F. J., and Wegener, H. C. 2006. "Web-based surveillance and global Salmonella distribution, 2000-2002." Emerging Infectious Diseases 12:381-388.
18. Gales, A. C., Jones, R. N., Gordon, K. A., Sader, H. S., Wilke, W. W., Beach, M. L., Pfaller, M. A., and Doern, G. V. 2000. "Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: Report from the second year of the SENTRY Antimicrobial Surveillance Program (1998)." Journal Antimicrobial Chemotherapy 45:295-303.
19. Gales, A. C., Sader, H. S., and Jones, R. N. 2002a. "Urinary tract infection trends in Latin American hospitals: Report from the SENTRY antimicrobial surveillance program (1997-2000)." Diagnostic Microbiology and Infectious Diseases 44:289-299.
20. Gales, A. C., Sader, H. S., Mendes, R. E., and Jones, R. N. 2002b. "Salmonella spp. isolates causing bloodstream infections in Latin America: Report of antimicrobial activity from the SENTRY Antimicrobial Surveillance Program (1997-2000)." Diagnostic Microbiology and Infectious Diseases 44:313-318.
21. Jorgensen, J. H., Crawford, S. A., and Fiebelkorn, K. R. 2005. "Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms affecting some agents." Journal of Clinical Microbiology 43:3162-3171.
22. Kotloff, K. L., Winickoff, J. P., Ivanoff, B., Clemens, J. D., Swerdlow, D. L., Sansonetti, P. J., Adak, G. K., and Levine, M. M. 1999. "Global burden of Shigella infections: Implications for vaccine development and implementation of control strategies." Bulletin of the World Health Organization 77:651-666.
23. Lincopan, N., McCulloch, J. A., Reinert, C., Cassettari, V. C., Gales, A. C., and Mamizuka, E. M. 2005. "First isolation of metallo-b-lactamase-producing multiresistant Klebsiella pneumoniae from a patient in Brazil." Journal of Clinical Microbiology 43:516-519.
24. Manchanda, V., and Bhalla, P. 2006. "Emergence of non-ceftriaxone-susceptible Neisseria meningitidis in India." Journal of Clinical Microbiology 44:4290-4291.
25. Melano, R., Corso, A., Petroni, A., Centron, D., Orman, B., Pereyra, A., Moreno, N., and Galas, M. 2003. "Multiple antibiotic-resistance mechanisms including a novel combination of extended-spectrum beta-lactamases in a Klebsiella pneumoniae clinical strain isolated in Argentina." Journal of Antimicrobial Chemotherapy 52:36-42.
26. Mendes, R. E., Bell, J. M., Turnidge, J. D., Yang, Q., Yu, Y., Sun, Z., and Jones, R. N. 2008. "Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a conjugative plasmid (blaKPC-2 + qnrB4) and a blaIMP-4." Antimicrobial Agents and Chemotherapy 52:798-799.
27. Monteiro, J., Henriques, A. P. C., Santos, A. F., Matos, D. G. C., Perano, G., Asensi, M. D., and Gales, A. C. 2007. Carbapenem-resistant Klebsiella pneumoniae outbreak: Emergence of KPC-2-producing strains in Brazil, Abstr C2-1929. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, IL, 141.
28. Okeke, I. N., Laxminarayan, R., Bhutta, Z. A., Duse, A. G., Jenkins, P., O'Brien, T. F., Pablos-Mendez, A., and Klugman, K. P. 2005. "Antimicrobial resistance in developing countries. Part I: Recent trends and current status." The Lancet Infectious Diseases 5:481-493.
29. Pallecchi, L., Malossi, M., Mantella, A., Gotuzzo, E., Trigoso, C., Bartoloni, A., Paradisi, F., Kronvall, G., and Rossolini, G. M. 2004. "Detection of CTX-M-type b-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru." Antimicrobial Agents and Chemotherapy 48:4556-4561.
30. Peirano, G., Souza, F. S., and Rodrigues, D. P. 2006. "Frequency of serovars and antimicrobial resistance in Shigella spp. from Brazil." Memórias do Instituto Oswaldo Cruz 101:245-250.
31. Poirel, L., Pitout, J. D., and Nordmann, P. 2007. "Carbapenemases: Molecular diversity and clinical consequences." Future Microbiology 2:501-512.
32. Rao, P. S., Rajashekar, V., Varghese, G. K., and Shivananda, P. G. 1993. "Emergence of multidrug-resistant Salmonella typhi in rural southern India." American Journal of Tropical Medicine and Hygiene 48:108-111.
33. Rossi, F., Baquero, F., Hsueh, P. R., Paterson, D. L., Bochicchio, G. V., Snyder, T. A., Satishchandran, V., McCarroll, K., Di Nubile, M. J., and Chow, J. W. 2006. "In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends)." Journal of Antimicrobial Chemotherapy 58:205-210.
34. Sader, H. S., Bell, J. M., Jones, R. N., Fritsche, T. R., and Turnidge, J. D. 2007. Spectrum and potency of tigecycline tested against non-enteric Gram-negative bacilli collected across the Asia-Pacific region (2006)
35. Sader, H. S., Castanheira, M., Mendes, R. E., Toleman, M., Walsh, T. R., and Jones, R. N. 2005. "Dissemination and diversity of metallo-b-lactamases in Latin America: Report from the SENTRY Antimicrobial Surveillance Program." International Journal of Antimicrobial Agents 25:57-61.
36. Sader, H. S., Jones, R. N., Andrade-Baiocchi, S., and Biedenbach, D. J. 2002. "Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers." Diagnostic Microbiology and Infectious Diseases 44:273-280.
37. Stephens, D. S., Greenwood, B., and Brandtzaeg, P. 2007. "Epidemic meningitis, meningococcaemia, and Neisseria meningitidis." Lancet 369:2196-2210.
38. Streit, J. M., Jones, R. N., Toleman, M. A., Stratchounski, L. S., and Fritsche, T. R. 2006. "Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: Report from the SENTRY Antimicrobial Surveillance Program (2003)." International Journal of Antimicrobial Agents 27:378-386.
39. Talukder, K. A., Khajanchi, B. K., Islam, M. A., Dutta, D. K., Islam, Z., Safa, A., Khan, G. Y., Alam, K., Hossain, M. A., Malla, S., Niyogi, S. K., Rahman, M., Watanabe, H., Nair, G. B., and Sack, D. A. 2004. "Genetic relatedness of ciprofloxacin-resistant Shigella dysenteriae type 1 strains isolated in south Asia." Journal of Antimicrobial Chemotherapy 54:730-734.
40. Taneja, N. 2007. Changing epidemiology of shigellosis and emergence of ciprofloxacinresistant Shigellae in India. Journal of Clinical Microbiology 45:678-679.
41. Tapsall, J. W. 2001. Antimicrobial resistance in Neisseria gonorrhoeae. Available at: http://www.who.int/drugresistance/Antimicrobial-resistance-in-Neisseria-gonorrhoeae.pdf. Geneve, Switzerland: Department of Communicable Diseases Surveillance and Response.
42. Van Dyck, E., Karita, E., Abdellati, S., Dirk, V. H., Ngabonziza, M., Lafort, Y., and Laga, M. 2001. "Antimicrobial susceptibilities of Neisseria gonorrhoeae in Kigali, Rwanda, and trends of resistance between 1986 and 2000." Sexually Transmitted Diseases 28:539-545.
43. Villegas, M. V., Lolans, K., Correa, A., Suarez, C. J., Lopez, J. A., Vallejo, M., and Quinn, J. P. 2006. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrobial Agents and Chemotherapy 50:2880-2882.
44. Walther-Rasmussen J, and Høiby N. 2006. OXA-type carbapenemases. Journal of Antimicrobial Chemotherapy 57:373-83.
45. Wang, H., and Chen, M. 2005. "Surveillance for antimicrobial resistance among clinical isolates of Gram-negative bacteria from intensive care unit patients in China, 1996 to 2002." Diagnostic Microbiology and Infectious Diseases 51:201-208.
46. WHO. 2006. World Health Organization. "Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2004." Communicable Diseases Intelligence 30:129-132.
47. WHO Global Salm-Surv. 2007. Progress report (2000-2005): Building capacity for laboratory-based foodborne disease surveillance and outbreak detection and response (http://www.who.int/salmsurv/links/GSSProgressReport2005.pdf). Accessed November 2007.
48. Wu, J. J., Ko, W. C., Tsai, S. H., and Yan, J. J. 2007. "Prevalence of plasmid-mediated quinolone resistance determinants qnrA, qnrB, and qnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital." Antimicrobial Agents and Chemotherapy 51:1223-1227.
49. Yildirim, I., Ceyhan, M., Gur, D., Mugnaioli, C., and Rossolini, G. M. 2007. "First detection of VIM-1 type metallo-β-lactamase in a multidrug-resistant Klebsiella pneumoniae clinical isolate from Turkey also producing the CTX-M-15 extended-spectrum β-lactamase." Journal of Chemotherapy 19:467-468.
50. Yuksel, S., Ozturk, B., Kavaz, A., Ozcakar, Z. B., Acar, B., Guriz, H., Aysev, D., Ekim, M., and Yalcinkaya, F. 2006. "Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections." International Journal of Antimicrobial Agents 28:413-416.